July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the ...

BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an ...

Celestica is a strong company, with a remarkable and fortunate market position, but the valuation is now too high for strong ...

Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...

Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

AbbVie ABBV has been actively ramping up its deal-making efforts lately, thereby strengthening its pipeline. While immunology ...